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Introduction: Liver cavernous hemangioma is the most common noncystic hepatic lesion, and a hemangioma that
undergoes degeneration and fibrous replacement is called a hepatic sclerosed hemangioma.
Case presentation: A 63-year-old Japanese man was admitted for detailed investigation of a liver tumor. Tumor
markers carcinoembryonic antigen, alpha-fetoprotein, and CA19-9 levels in the peripheral blood were not elevated
at any time. Plain computed tomography showed an approximately 1.5cm low density mass in the periphery of
segment 8, which was marginally enhanced on contrast-enhanced dynamic computed tomography. On magnetic
resonance imaging, the tumor was hypointense on T1-weighted image and hyperintense on T2-weighted image.
The tumor was suspected to be an atypical hemangioma, metastatic, hepatocellular carcinoma, or cholangiocellular
carcinoma. Segmental hepatectomy was performed. Histological examination of the resected tumor specimen
revealed a sclerosed hemangioma with marked hyalinization and sparse stromal fibrosis. Immunochemically, the
tumor cells were positive for CD34 and alpha smooth muscle actin. Electron microscopically, the residual
hemangioma consisted of numerous caveolae and vesicles in endothelial cells in irregular shapes and sizes.
Immunostaining for caveolin-1 showed decreased or no caveolin-1 reactivity in the hyalinized lesions of the
sclerosed hemangioma, but abundant caveolin-1 reactivity in the residual cavernous hemangioma. Of interest,
computed tomography images of the tumor obtained 10 years earlier at our hospital depicted a 3cm typical
cavernous hemangioma.
Conclusions: Hepatic sclerosed hemangioma is a rare condition. Comparison of radiological findings of the lesion
over a period of 10 years was valuable in providing insight for the evolutional process from liver cavernous
hemangioma to hepatic sclerosed hemangioma.
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Liver cavernous hemangiomaIntroduction
Liver cavernous hemangioma (LCH) is the most common
noncystic hepatic lesion, with a reported incidence of 20%
of benign hepatic tumors [1]. Most hemangiomas remain
stable on follow-up imaging [2]; growth and spontaneous
regression are reported to be very rare [3]. LCH that have
undergone degeneration and fibrous replacement are called
sclerosed, thrombosed, or hyalinized hemangiomas [4]. On* Correspondence: yokomori@insti.kitasato-u.ac.jp
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reproduction in any medium, provided the orthe one hand, Shepherd and Lee [5] first mentioned hepatic
sclerosed hemangioma (HSH) as a differential diagnosis of
solitary necrotic nodules in addition to a list of benign le-
sions including traumatic etiology, a sequel of previous in-
fection, and LCH. On the other hand, Berry [6] suggested
that solitary necrotic nodules might all be HSH.
Computed tomography (CT) features suggestive of
HSH include geographic outline, capsular retraction, de-
crease in size over time, and loss of previously observed
regions of enhancement. Additional features include the
presence of transient hepatic attenuation difference, rimal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ment as seen in typical hemangiomas [7]. The common
histological features of HSH comprise multiple thin walled
vessels within a hypocellular stroma demonstrating vary-
ing degrees of fibrosis and sclerosis. Macroscopically, a
hemangioma is usually reddish-blue and well demarcated
from surrounding tissue. However, the sclerosed variant is
seen as a pale nodule if there is significant fibrosis present.
The cell type of origin is mesenchymal and as such the le-
sions can occur almost anywhere [8]. Makhlouf and Ishak
[9] suggested that mast cells play a pivotal role in the de-
velopment of HSH, perhaps representing a distinct histo-
logical subtype of liver lesion. In the present case,
radiological images obtained 10 years earlier were available
for comparison, which were valuable in providing insights
to the evolutional process from LCH to HSH.
Caveolae are cell plasma membrane microdomains and
are responsible for transmembrane trafficking, endocytosis
and lipid homeostasis, and also serve in signaling pro-
cesses as a compartment where receptors and signaling
proteins are concentrated [10]. Caveolin-1 in endothelialFigure 1 Abdominal contrast-enhanced dynamic computed tomograp
density mass in the periphery of segment 8 (arrow). b: Early arterial phase
enhanced. Small satellite-like lesions (arrow) are found close to the main tu
in segment 8 (arrow). d: Delayed-phase image (180 seconds) of enhanced
denotes hepatic mass lesion.cells regulates angiogenesis, microvascular permeability
and vascular remodeling [10,11]. Apart from its signaling
function in normal cells, caveolin-1 also functions as a
tumor suppressor and pro-apoptotic protein [12]. Previous
study has indicated that this protein is overexpressed in
different cancers and that it might serve as a prognostic
factor for patient outcome or contribute to metastatic
spread [13]. Caveolin expression has been described in a
range of vascular neoplasms including lobular capillary
hemangiomas, targetoid hemosiderotic hemangiomas, and
tufted angiomas, and decreased expression of this protein
was detected in angiosarcomas, Kaposi’s sarcoma, and epi-
thelioid hemangioendotheliomas [14]. These findings sug-
gest that anti-caveolin antibodies may play a useful role in
distinguishing benign from malignant vascular neoplasms.
In the present case, we investigated caveolin-1 expression
of HSH by immunohistochemistry.
Case presentation
A 63-year-old Japanese man was transferred to our hos-
pital for detailed investigation of a liver tumor. Athy (CT) findings. a: Plain CT shows an approximately 1.5cm low-
image (40sec) of enhanced CT shows that the tumor is marginally
mor. c: Portal venous phase image of enhanced CT shows the tumor
CT shows faint enhancement of a small portion of the tumor. Arrow
Figure 2 Magnetic resonance imaging findings. a: T1-weighted image demonstrates the tumor as a hypointense area with satellite-like lesions
in segment 8 (arrow). b: T2-weighted image shows the main tumor as a slight hyperintense area (arrow). c: A diffusion-weighted image depicts
the main tumor as a slightly hyperintense area (arrow). d-h: Dynamic gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced
magnetic resonance imaging of the tumor (arrow).
Figure 3 Gross appearance of the sclerosed hemangioma. The
surface discloses a well-demarcated homogenous gray-white solid
nodule, measuring 1cm at its greatest dimension.
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chemistry data were as follows: white blood cell count
3,800/μL, hemoglobin 15.9g/dL, platelet count 146,000/
μL, blood urea nitrogen 17.9mg/dL, creatinine 0.82mg/
dL, albumin 4.3g/dL, aspartate aminotransferase 26IU/L,
alanine aminotransferase 33IU/L, and total bilirubin
0.9mg/dL. Serum hepatitis B (HB) surface antigen, anti-
HBe antibody, and anti-hepatitis C virus antibody were
negative. Alpha-fetoprotein, carcinoembryonic antigen,
and cancer antigen 19–9 levels were within the normal
ranges. Dynamic CT depicted a mass measuring 1.5 ×
1.4cm with a bulging contour in segment 8 of the liver,
which was enhanced in the arterial phase and showed sub-
tle low density with focal capsular enhancement in the de-
layed phase (Figure 1). A magnetic resonance image (MRI)
demonstrated low signal intensity on T1-weighted image,
and slightly high signal intensity on T2-weighted and
diffusion-weighted images (Figure 2a–c). Dynamic contrast
(gadolinium ethoxybenzyl diethylenetriaminepentaacetic
acid)-enhanced MRI of the tumor showed subtle marginal
enhancement in the delayed phase and well-demarcated
low intensity in the hepatobiliary phase (Figure 2d-h). Gas-
troscopy revealed atrophic gastritis and colonoscopy
showed normal findings.
Based on the radiologic findings, we suspected the
tumor to be an atypical hemangioma, metastatic, hepato-
cellular carcinoma, or a cholangiocellular carcinoma. Due
to a suspicion of carcinoma, a hepatic segmentectomy of
segment 8 was performed. On pathological examination,
the resected liver tumor measured 1.1cm × 1.1cm × 1.0cm.
Sectioning revealed a relatively homogenous, well-
circumscribed white solid nodule with several dark-red,pin-point spots (Figure 3). Histopathological evaluation re-
vealed that most areas were composed of sclerotic
hyalinized collagenous tissues with scattered tiny-to-small,
thin-walled vascular spaces (Figure 4a and b). The vascular
spaces were frequently collapsed and lined by flat
Figure 4 Histologic features of the sclerosed hemangioma nodule. a: A hyalinized mass is distinguished from the surrounding normal liver
tissue (hematoxylin and eosin staining). b:The mass is composed of collapsed vascular spaces on a rich paucicellular fibrous stroma. Sclerosis is
highlighted by Masson’s trichrome stain. c: The vascular spaces are clearly identified by immunohistochemistry for the endothelial marker CD34.
d: The vascular and cavernous hemangioma spaces are identified by immunohistochemistry for the vascular smooth muscle cell marker, alpha
smooth muscle actin. Asterisks denote sclerosed portion.
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that the cells were positive for CD34, an endothelial
marker (Figure 4c) and alpha smooth muscle actin, a
marker of vascular smooth muscle (Figure 4d). Based on
these pathological findings, the tumor was diagnosed
as HSH.
Furthermore, we also observed the tumor by electron
microscopy and investigated the expression of caveolin-1
by immunohistochemistry (Additional file 1). On elec-
tron micrograph, the tumor appeared to be hyalinized.
Cells resembling mast cells or histiocytes, fibroblast-like
cells, and remnant endothelial cells were observed
(Figure 5a). Remnant endothelial cells contained a few
micropinocytic vesicles and caveolae, but numerous
cytoplasmic filaments (Figure 5b). We also found re-
sidual LCH composed of numerous caverns in variousshapes and sizes. The caverns formed a labyrinth, com-
municating with each other. They were lined by spindle-
shaped endothelial cells (Figure 5c). The endothelial cells
also contained numerous cytoplasmic filaments (Figure 5d).
Moreover, caveolae and multiple micropinocytic vesicles
were observed along the luminal and basal cell surfaces.
Slender intraluminal processes were also found, sometimes
overlapping with the cytoplasmic extensions from other
cells (Figure 5c and d). Immunohistochemistry revealed
caveolin-1 expression on the hepatic artery, capillary ve-
nules, portal vein in the portal tract, and in the hepatic si-
nusoidal lining cells around pericentral zone 3 in normal
control liver areas (Figure 6a-c). Caveolin-1 remained
overexpressed in the endothelial cells of the capillary tufts
at the edge of the residual LCH but was reduced in the
sclerosed hyaluronic lesion (Figure 6d-f). High expression
Figure 5 Electron microscopic findings. a: Electron micrograph shows a hyalinized lesion. Cells resembling histiocytes, fibroblast-like cells, and
remnant endothelial cells derived from sclerosed hemangioma are observed. White arrowheads denote histiocytes or mast cells. Bar denotes
5μm. b: At high magnification, a remnant endothelial cell contains a few micropinocytic vesicles and caveolae, but numerous cytoplasmic
filaments. White arrowheads denote caveolae. Bar denotes 500nm. c: Residual hemangioma is composed of numerous caverns in various shapes
and sizes. The caverns form a labyrinth, communicating with each other. They are lined by spindle-shaped endothelial cells. Bar denotes 5μm. d:
At high magnification, residual endothelial cells are composed of many micropinocytic vesicles or caveolae on the luminal surface. Residual
cavernous hemangioma contains numerous cytoplasmic filaments. White arrowheads denote caveolae and vesicles. Bar denotes 500nm. Uranyl
acetate and lead citrate staining.
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hemangioma (Figure 6e). Caveolin-1 immunostaining was
nearly absent in fibroblasts (Figure 6f).
CT images obtained from the same patient 10 years
ago were available, and provided insight for the evolu-
tional process from LCH (showing peripheral high at-
tenuation in the early phase and homogeneous high
attenuation in the late phase; Figure 7a and b) to HSH
(showing peripheral high density in the arterial phase
and subtle low density with focal capsular enhancement
in the delayed phase; Figure 1).
The postoperative course was uneventful and the pa-
tient was discharged after 2 weeks.Discussion
HSH is a rare condition. In the present case, we investi-
gated the HSH using electron microscopy and immuno-
histochemical methods. LCH are usually found
incidentally and are readily diagnosed from their charac-
teristic homogeneous hyperechogenicity and posterior
acoustic enhancement on ultrasound examination. They
may sometimes present different stages of evolution. In
these cases, radiological findings show atypical features,
occasionally mimicking malignant lesions [15]. Although
not pathognomonic, some features of HSH may suggest
a presumptive diagnosis and lead to biopsy rather than
more extensive intervention [7]. Due to a suspicion of
Figure 6 Immunostaining for caveolin-1 in normal liver areas (a-c) and the lesion (d-f). For the lesion, immunostaining was performed on
serial sections continuous with those used in Figure 4. a-c: normal liver areas a: Abundant caveolin-1 reactivities are seen in both the endothelial
cells as well as smooth muscle cells in normal areas. P denotes portal tract. C denotes central vein. Bar denotes 154μm. b: Caveolin-1 reactivities
are noted on the hepatic artery, capillary venules, and portal vein in the portal tract in normal control liver areas. Arrow heads denote hepatic
artery, capillary venules, and portal vein. Bar denotes 32μm. c: Caveolin-1 reactivities are detected in the hepatic sinusoidal lining cells around
pericentral zone 3 in normal control liver areas. Arrowheads denotes liver sinusoidal lining cell. Bar denotes 32μm. d-f: lesion. d: Caveolin-1
reactivities are reduced or absent in the hyalinized lesions of sclerosed hemangioma. In residual hemangioma, high expression of caveolin 1 is
found in endothelial cells. Caveolin-1 reactivity is almost absent in fibroblasts. Asterisks denote sclerosed portion. Bar denotes 153μm. e: Lesion of
liver cavernous hemangioma lesion. Arrowhead denotes endothelial cells. Bar denotes 32μm. f: Lesion of sclerosed hepatic hemangioma.
Arrowhead denotes endothelial cell. Bar denotes 32μm. Red rectangles denote the regions seen in 6b or 6c and 6e or 6f, respectively.
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in the present case. Some pathological changes are re-
sponsible for the variations of the radiological findings
of hemangioma. Of these complications, sclerosing hem-
angiomas may have a variable amount of stroma, varying
from scanty (fibrillar or hyaline) to abundant (hyaline or
sclerotic), and sclerosed hemangiomas are characterized
by extensive fibrosis with subsequent hyalinization and
marked narrowing or obliteration of the vascular spaces
[16]. Makhlouf and Ishak [9] reported distinct clinical andhistopathological differences between sclerosing cavernous
hemangioma and HSH, and suggested that recent
hemorrhage, hemosiderin deposits, and abundant mast
cells are present in sclerosing hemangioma. In our case,
HSH was presumptively diagnosed from light microscopic
observations of extensive fibrosis with hyalinization and
marked narrowing or obliteration of the vascular spaces.
Makhlouf and Ishak [9] also reported the possible involve-
ment of mast cells in angiogenesis, the regression process
and the development of fibrosis. According to their report,
Figure 7 Two-phase dynamic incremental computed tomography (CT) of the lesion performed 10 years ago. a: In the early phase CT
image, the lesion in segment 8 shows peripheral high attenuation. b: The late phase CT image demonstrates homogeneous high attenuation.
These images demonstrate the progressive, centripetal contrast enhancement in a liver cavernous hemangioma.
Shimada et al. Journal of Medical Case Reports 2013, 7:139 Page 7 of 9
http://www.jmedicalcasereports.com/content/7/1/139sclerosing hemangiomas show immunopositivity more fre-
quently for collagen IV, laminin, factor VIII-R antigen,
CD34 and CD31, as well as increased immunoreactivity for
smooth muscle actin when compared with sclerosed hem-
angiomas. Moreover, fibrosis, increased elastic fibers, and
dystrophic or psammomatous calcifications with a de-
creased number of mast cells can be observed in the scler-
osed hemangioma [9]. In our present case, HSH was
definitively diagnosed based on routine hematoxylin and
eosin and Masson trichrome staining, as well as CD34 im-
munostaining (Figure 4).
In the present case, a CT showed an heterogeneous en-
hancement at the marginal portion of the tumor. MRI
showed a hypointense tumor on T1-weighted image and a
hyperintense tumor on T2-weighted image. A dynamic
gadolinium ethoxybenzyl diethylenetriamine pentaacetic
acid (Gd-EOB-DTPA)-enhanced MRI study showed an in-
ternal heterogeneous mass. T2-weighted MRI showed the
mass as hypointense in relation to cerebrospinal fluid. Al-
though the final diagnosis of HSH was made histopatho-
logically, understanding of its radiologic appearance is
important to avoid unnecessary surgery, and HSH should
be included in the differential diagnoses of a hepatic lesion
with delayed enhancement [17]. In the present case, the
main tumor was shown as a slightly hyperintense area on
diffusion-weighted MRI image. Hida et al. [18] reported
that HSH had a high apparent diffusion coefficient (ADC)
on MRI. Therefore, HSH cannot be differentiated from
hepatic metastasis and cholangiocellular carcinoma based
on the MRI findings. The presence of many hyalinized tis-
sues with poor cellular and fibrous components as re-
vealed microscopically might be a cause of the high ADC
value. Based on the radiologic findings and due to a suspi-
cion of carcinomas, we performed a segmentectomy.Electron microscopy showed a hyalinized lesion, with
cells resembling histiocytes and fibroblasts. In a previous
study, the number of mast cells correlated significantly
with vascular proliferation and correlated inversely with
the degree of fibrosis [9]. Gross and Wolbach [19] were
the first to describe sclerosing hemangioma as having
endothelial origin. They recognized a spectrum of histo-
logical changes from the early overgrowth of fibrous tis-
sue in a hemangioma to the complete replacement of
hemangiomatous structures by fibrosis and accumula-
tion of lipid and hemosiderin-laden histiocytes. These
changes are thought to represent regressive phenomena
that occur in varying degrees leading eventually to a
number of different patterns.
Immunohistochemical, electron microscopic, and vari-
ous molecular pathological techniques have been utilized
to diagnose pulmonary sclerosing hemangioma [20]. The
cause of the sclerosed process, which eventually destroys
the blood vessels, remains unknown. Whether the stimu-
lus leading to sclerosis is initiated by the endothelial cells
or by the surrounding fibroblasts is uncertain. In view of
the fact that endothelial cells may act as facultative fibro-
blasts and become ultrastructurally similar to fibroblasts,
we favor the former. Our immunohistochemical staining
for caveolin-1 and electron microscopic findings shed new
light on the process of dysregulated angiogenesis in this
very rare disorder. In electron microscopic study, we
showed that LCH are composed of numerous caverns in
various shapes and sizes. The caverns form a labyrinth,
communicating with each other. They are lined by
spindle-shaped endothelial cells containing multiple
micropinocytic vesicles or caveolae along the luminal sur-
face. Caveolin-1 remains overexpressed in the endothelial
cells of the capillary tufts at the edge of the hemangioma
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and b). Hemangioma has been reported to be composed
of numerous caves forming a labyrinth with narrow
interconnecting canals and lined by spindle-shaped endo-
thelial cells with multilayered smooth muscle cells [21,22].
We demonstrated endothelial cells together with multi-
layered smooth muscle cells by electron microscopy and
the difference between high expression of caveolin-1 in
the endothelial cells and scanty expression of fibroblasts
by immunohistochemistry. Caveolin-1 inhibits vascular
smooth muscle cell (VSMC) proliferation in part by
modulating key cycle-regulatory proteins. Furthermore,
overexpression of caveolin-1 has a dramatic effect on
VSMC response to growth stimuli, including induction of
apoptosis [23]. Caveolin-1 immunostaining of endothe-
lium showed increased punctuate caveolin-1 reactivity on
a few or none of the pericytes [24]. Caveolin-1 expression
has been described in a range of vascular neoplasms [14],
and caveolin-1 in endothelial cells regulates microvascular
permeability [10]. In our ultrastructural findings, numer-
ous caveolae were found in cavernous hepatic endothelial
cells of the residual cavernous hemangioma. By contrast, a
few caveolae were found in the remnant capillary endothelial
cells of HSH. Functionally, caveolae of cavernous hepatic
endothelial cells can interact with numerous kinds of extra-
cellularmatrixmolecules and facilitate angiogenesis [25].
Conclusions
HSH is a rare condition. Comparison of radiological
findings of the lesion over a period of 10 years was valu-
able in providing insight for the evolutional process from
cavernous hemangioma to sclerosed hemangioma.
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